Healthcare

According to a market report by Lucintel, the future of the vaccine market looks promising with opportunities in the pediatrics and adults end use segments. The global vaccine market is expected to reach an estimated $94.0 billion by 2028 with a CAGR of 8.6% from 2023 to 2028. The major drivers for this market are growing prevalence of infectious diseases, increasing consumer awareness towards immunization, and introduction of vaccination programs by governments to prevent dangerous diseases or infections, including tuberculosis, cancer, hepatitis, and influence.



In this market, conjugate, inactivated & subunit, live attenuated, recombinant, toxoid, mRNA, and viral vector are the major segments by technology. Lucintel forecasts that conjugate will remain the largest technology segment over the forecast period because it helps in preventing invasive pneumococcal diseases. 



Within this market, pediatrics is expected to remain the largest segment due to the supportive initiative by governments and businesses to create vaccines for pediatric population to prevent serious illness. 



North America will remain the largest region due to increasing awareness of vaccination and supporting government policies for health welfare.

GlaxoSmithKline, Merck & Co., Pfizer, Sanofi SA, and CSL are the major suppliers in the global vaccine market.



Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global vaccine market by technology, product type, disease indication, route of administration, end use, and region. Lucintel has compiled a comprehensive research report entitled “Growth Opportunities in the Global Vaccine Market 2023-2028: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global vaccine market by technology, product type, disease indication, route of administration, end use, and region, as follows:

This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or email us at helpdesk@lucintel.com.

 

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. Lucintel offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

 

Q.1. What are some of the most promising, high-growth opportunities for the vaccine market by technology (conjugate, inactivated & subunit, live attenuated, recombinant, toxoid, viral vector, mRNA, viral vector, and others), product type (monovalent and multivalent), disease indication (influenza, pneumococcal diseases, combination vaccines, HPV, herpes zoster, meningococcal diseases, rotavirus, MMR, varicella, hepatitis, DTP, Polio, COVID 19, and others), route of administration (intramuscular & subcutaneous administration, oral administration, and others), end use (pediatrics and adults), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?